Abstract: This antibacterial agent comprises a blocked isocyanate. The blocked isocyanate comprises a capped polyisocyanate residue (A), an antibacterial-non-block cap group (B), and a non-antibacterial-block cap group (C). The capped polyisocyanate residue (A) is produced by capping a plurality of isocyanate groups in a polyisocyanate having the isocyanate groups. In the antibacterial-non-block cap group (B), at least some of the plurality of isocyanate groups are capped in a non-reproducible manner. In the non-antibacterial-block cap group (C), at least some of the plurality of isocyanate groups are capped in a reproducible manner. The antibacterial-non-block cap group (B) includes a quaternary ammonium group.
| # | Name | Date |
|---|---|---|
| 1 | 202417063822-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [23-08-2024(online)].pdf | 2024-08-23 |
| 2 | 202417063822-STATEMENT OF UNDERTAKING (FORM 3) [23-08-2024(online)].pdf | 2024-08-23 |
| 3 | 202417063822-REQUEST FOR EXAMINATION (FORM-18) [23-08-2024(online)].pdf | 2024-08-23 |
| 4 | 202417063822-PROOF OF RIGHT [23-08-2024(online)].pdf | 2024-08-23 |
| 5 | 202417063822-PRIORITY DOCUMENTS [23-08-2024(online)].pdf | 2024-08-23 |
| 6 | 202417063822-FORM 18 [23-08-2024(online)].pdf | 2024-08-23 |
| 7 | 202417063822-FORM 1 [23-08-2024(online)].pdf | 2024-08-23 |
| 8 | 202417063822-DECLARATION OF INVENTORSHIP (FORM 5) [23-08-2024(online)].pdf | 2024-08-23 |
| 9 | 202417063822-COMPLETE SPECIFICATION [23-08-2024(online)].pdf | 2024-08-23 |
| 10 | 202417063822-FORM-26 [26-08-2024(online)].pdf | 2024-08-26 |
| 11 | 202417063822-GPA-300824.pdf | 2024-09-02 |
| 12 | 202417063822-Correspondence-300824.pdf | 2024-09-02 |
| 13 | 202417063822-MARKED COPIES OF AMENDEMENTS [05-09-2024(online)].pdf | 2024-09-05 |
| 14 | 202417063822-FORM 13 [05-09-2024(online)].pdf | 2024-09-05 |
| 15 | 202417063822-AMMENDED DOCUMENTS [05-09-2024(online)].pdf | 2024-09-05 |
| 16 | 202417063822-FORM 3 [09-01-2025(online)].pdf | 2025-01-09 |